States reporting vaccine shortages
Some appointments getting canceled; reason could be unrealistic supply expectations
New York — The push to inoculate Americans against the coronavirus is hitting a roadblock: A number of states are reporting they are running out of vaccine, and tens of thousands of people who managed to get appointments for a first dose are seeing them canceled.
Karen Stachowiak, a first-grade teacher in the Buffalo area, spent almost five hours on the state hot line and website to land an appointment for Wednesday, only to be told it was canceled. The Erie County Health Department said it scratched vaccinations for over 8,000 people in the past few days because of inadequate supply.
“It’s stressful because I was so close. And my other friends that are teachers, they were able to book appointments for last Saturday,” Stachowiak said. “So many people are getting theirs in, and then it’s like, ‘Nope, I’ve got to wait.’”
The reason for the apparent mismatch between supply and demand in the U.S. was unclear, but last week the Health and Human Services Department suggested that states had unrealistic expectations for how much vaccine was on the way.
In any case, new shipments go out every week, and both the government and the drugmakers have said there are large quantities in the pipeline.
The shortages are coming as states dramatically ramp up their vaccination drives, at the federal government’s direction, to reach people 65 and older, along with certain others. More than 400,000 deaths in the U.S. have been blamed on the virus.
President Joe Biden, who was inaugurated on Wednesday, immediately came under pressure to fix things. He has made it clear that his administration will take a stronger hand in attacking the crisis, and he vowed to administer 100 million shots in his first 100 days.
Less than half of the 36 million doses distributed to the states by the federal government have been administered so far, according to the Centers for Disease Control and Prevention. Public health officials have said the gap could reflect recordkeeping delays as well as disarray and other failings at various levels of government in actually getting shots into arms.
In a statement, HHS said that jurisdictions actually received about a 5% increase in vaccine allocations this week from what they got in the past couple of weeks.
Countries across Europe are also having problems getting enough doses to provide protection against a virus that is now appearing in new, more contagious variants around the globe.
Pfizer said last week it would temporarily reduce deliveries to Europe and Canada while it upgrades capacity at its plant in Belgium, which supplies all shots delivered outside the United States. Pfizer’s primary site for manufacturing vaccine for the U.S. is in Kalamazoo, Michigan.
In the U.S., some states have suggested they may run out by today and are unclear when new doses will arrive.